Irish Medicines Database — 10,165 HPRA-Authorised Products

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

491 results for “Novo”

Medicine	Active substance	Licence holder	Status
Sacubitril/Valsartan Krka 97 mg/103 mg film-coated tablets PA1347/119/003	Sacubitril sodium, Valsartan disodium	KRKA, d.d., Novo mesto	Not marketed
Saxenda 6 mg/ml solution for injection in pre-filled pen EU/1/15/992/001-003	Liraglutide	Novo Nordisk A/S	—
Septabene 1.5 mg/ml + 5.0 mg/ml oromucosal spray, solution PA1347/049/001	BENZYDAMINE HYDROCHLORIDE, Cetylpyridinium chloride	KRKA, d.d., Novo mesto	Not marketed
Septabene eucalyptus 3 mg/1 mg lozenges PA1347/063/001	BENZYDAMINE HYDROCHLORIDE, Cetylpyridinium chloride	KRKA, d.d., Novo mesto	Not marketed
Septabene lemon and elderflower 3 mg /1 mg lozenges PA1347/063/003	BENZYDAMINE HYDROCHLORIDE, Cetylpyridinium chloride	KRKA, d.d., Novo mesto	Not marketed
Septabene Lemon and Honey 3 mg/1 mg lozenges PA1347/063/002	BENZYDAMINE HYDROCHLORIDE, Cetylpyridinium chloride	KRKA, d.d., Novo mesto	Not marketed
Septanazal 1 mg/ 50 mg in 1 ml nasal spray solution PA1347/058/002	Xylometazoline hydrochloride, Dexpanthenol	KRKA, d.d., Novo mesto	Not marketed
Septanazal for children 0.5 mg/ 50 mg in 1 ml nasal spray solution PA1347/058/001	Xylometazoline hydrochloride, Dexpanthenol	KRKA, d.d., Novo mesto	Not marketed
Sertraline Krka 100 mg film-coated tablets PA1347/019/002	Sertraline	KRKA, d.d., Novo mesto	Marketed
Sertraline Krka 50 mg film-coated tablets PA1347/019/001	Sertraline	KRKA, d.d., Novo mesto	Marketed
Simvastatin Krka 10 mg Film-Coated Tablets PA1347/028/001	Simvastatin	KRKA, d.d., Novo mesto	Marketed
Simvastatin Krka 20 mg Film Coated Tablets PA1347/028/002	Simvastatin	KRKA, d.d., Novo mesto	Marketed
Simvastatin Krka 40 mg Film Coated Tablets PA1347/028/003	Simvastatin	KRKA, d.d., Novo mesto	Marketed
Sitagliptin Krka 100 mg film-coated tablets PA1347/094/003	Sitagliptin	KRKA, d.d., Novo mesto	Marketed
Sitagliptin Krka 25 mg film-coated tablets PA1347/094/001	Sitagliptin	KRKA, d.d., Novo mesto	Marketed
Sitagliptin Krka 50 mg film-coated tablets PA1347/094/002	Sitagliptin	KRKA, d.d., Novo mesto	Marketed
Sitagliptin/Metformin hydrochloride Krka 50 mg/1000 mg film-coated tablets PA1347/100/002	Sitagliptin, Metformin Hydrochloride	KRKA, d.d., Novo mesto	Marketed
Sitagliptin/Metformin hydrochloride Krka 50 mg/850 mg film-coated tablets PA1347/100/001	Sitagliptin, Metformin Hydrochloride	KRKA, d.d., Novo mesto	Marketed
Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen EU/1/20/1501/001-002	Somapacitan	Novo Nordisk A/S	—
Sogroya 15 mg/1.5 mL solution for injection in pre-filled pen EU/1/20/1501/005-006	Somapacitan	Novo Nordisk A/S	—
Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen EU/1/20/1501/003-004	Somapacitan	Novo Nordisk A/S	—
Tadalafil Krka 10 mg film-coated tablets PA1347/071/003	Tadalafil	KRKA, d.d., Novo mesto	Marketed
Tadalafil Krka 2.5 mg film-coated tablets PA1347/071/001	Tadalafil	KRKA, d.d., Novo mesto	Not marketed
Tadalafil Krka 20 mg film-coated tablets PA1347/071/004	Tadalafil	KRKA, d.d., Novo mesto	Marketed
Tadalafil Krka 5 mg film-coated tablets PA1347/071/002	Tadalafil	KRKA, d.d., Novo mesto	Not marketed
Tamzeltos 400 micrograms prolonged-release tablets PA1347/087/001	Tamsulosin hydrochloride	KRKA, d.d., Novo mesto	Not marketed
TANYZ 400 micrograms hard modified-release capsules PA1347/086/001	Tamsulosin hydrochloride	KRKA, d.d., Novo mesto	Not marketed
Ticagrelor Krka 60 mg film-coated tablets PA1347/102/001	Ticagrelor	KRKA, d.d., Novo mesto	Not marketed
Ticagrelor Krka 90 mg film-coated tablets PA1347/102/002	Ticagrelor	KRKA, d.d., Novo mesto	Marketed
Tolucombi 40 mg/12.5 mg tablets EU/1/13/821/001-010	Telmisartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	—
Tolucombi 80 mg/12.5 mg tablets EU/1/13/821/011-020	Telmisartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	—
Tolucombi 80 mg/25 mg tablets EU/1/13/821/021-030	Telmisartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	—
Tolura 20 mg tablets EU/1/10/632/001-7	Telmisartan	KRKA, d.d., Novo mesto	—
Tolura 40 mg tablets EU/1/10/632/008-14	Telmisartan	KRKA, d.d., Novo mesto	—
Tolura 80 mg tablets EU/1/10/632/015-21	Telmisartan	KRKA, d.d., Novo mesto	—
Tramadol Krka 50mg hard capsules PA1347/079/001	Tramadol hydrochloride	KRKA, d.d., Novo mesto	Marketed
Tramadol/Paracetamol Krka 37.5mg/325mg film-coated tablets PA1347/052/001	Paracetamol, Tramadol hydrochloride	KRKA, d.d., Novo mesto	Marketed
Tresiba 100 units/mL solution for injection in pre-filled pen EU/1/12/807/1,4,5,7,8	Insulin degludec (ideg)	Novo Nordisk A/S	—
Tresiba 200 units/mL solution for injection in pre-filled pen EU/1/12/807/9,12,13,15	Insulin degludec (ideg)	Novo Nordisk A/S	—
Trisequens film-coated tablets PA0218/008/001	Estradiol, Estradiol, Norethisterone acetate, Estradiol	Novo Nordisk A/S	Marketed
Vagifem 10 micrograms vaginal tablets PA0218/030/002	Estradiol	Novo Nordisk A/S	Marketed
Valsartan Krka 160 mg film-coated tablets PA1347/010/008	Valsartan	KRKA, d.d., Novo mesto	Marketed
Valsartan Krka 320 mg film-coated tablets PA1347/010/009	Valsartan	KRKA, d.d., Novo mesto	Not marketed
Valsartan Krka 40 mg film-coated tablets PA1347/010/006	Valsartan	KRKA, d.d., Novo mesto	Marketed
Valsartan Krka 80 mg film-coated tablets PA1347/010/007	Valsartan	KRKA, d.d., Novo mesto	Marketed
Valsartan/hydrochlorothiazide Krka 160 mg/12.5 mg film-coated tablets PA1347/004/002	Valsartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Marketed
Valsartan/hydrochlorothiazide Krka 160 mg/25 mg film-coated tablets PA1347/004/003	Valsartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Marketed
Valsartan/hydrochlorothiazide Krka 320 mg/12.5 mg film-coated tablets PA1347/004/004	Valsartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Marketed
Valsartan/hydrochlorothiazide Krka 320 mg/25 mg film-coated tablets PA1347/004/005	Valsartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Marketed
Valsartan/hydrochlorothiazide Krka 80 mg/12.5 mg Film-coated Tablets PA1347/004/001	Hydrochlorothiazide, Valsartan	KRKA, d.d., Novo mesto	Marketed

← 6 7 8 9 10 →

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.